Home >> News >> Business >> Bone Grafts And Substitutes Market Is Expected To Reach US$ 3,872.1 Mn By 2025

Bone Grafts And Substitutes Market Is Expected To Reach US$ 3,872.1 Mn By 2025

The latest market report published by Credence Research, Inc. “Bone Grafts and Substitutes Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global bone grafts and substitutes market was valued at US$ 2,419.2 Mn in 2016, and is expected to reach US$ 3,872.1 Mn by 2025 expanding at a CAGR of 5.72 % from 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Sterile Injectables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/bone-grafts-and-substitutes-market

Market Insights

According to the findings of United Nations, the prevalence of osteoarthritis is increasing due to aging population, osteoporosis and obesity; it is estimated by 2050 people aged above 60 years will account for 20% of the total world population with one third of this population suffering with osteoarthritis and osteoporosis. Conventional bone grafting has been used for decades but also is found incompetent in accelerating healing, reducing the time of weight bearing, and significant morbidity from the harvest site. Significant technological advancement in the synthetic bone grafts such as calcium phosphate cements, coralline hydroxyapatite has accelerated bone formation as its interconnected porous structure closely resembles the porosity of human cancellous bone will propel the market penetration for bone grafts and substitutes.

At present, allografts hold the largest market share due to key drivers such as rising prevalence of osteoporosis, sports injuries and it is cost effective procedure as it reduces the hospital stay. Additionally it is a quick surgical procedure and less anesthesia time is required. Bone graft substitutes show a promising sales forecast and will be the fastest growing market majorly due to factors such as rapid wound healing due to inherent features of bone substitutes such as negative surface charge, increased protein fusion, enhanced cell attachment and favorable natural remodeling and graft resorption.

Spinal fusion currently dominates the application segment due to factors such as rising prevalence of low spine disc herniation, burst fractures, osteoporosis etc. and increasing number of patients suffering with cauda equine syndrome are preferring spinal fusion surgeries to release pressure on many spinal nerves which causes paralysis in lower extremities. Dental surgeries are anticipated to be the fastest growing market majorly due to factors such as rising prevalence of periodontal disease, car accidents resulting dental trauma resulting in loss of teeth and gum causing deformation in outward cosmetic appearance and dental bone grafting is also employed to maintain bone structure after tooth extraction and improved oral health.

In the current scenario, North America dominates the regional markets and the growth is mainly attributed to the presence of key drivers such as rising prevalence of osteoporosis and periodontal diseases in the elderly population, existence of developed healthcare facilities and presence of major players engaged in the manufacture and sale of bone grafts and substitutes. Asia Pacific promises a lucrative market with promising sales forecast chiefly due to factors that are anticipated to propel the market growth in Asia Pacific are the rising prevalence of traumatic injuries due to accidents, violence etc., flourishing e-commerce industry to promote sales and supportive regulatory environment for bone grafts and substitutes.

The bone grafts and substitutes market is technologically driven and includes major players such as AlloSource, Baxter Healthcare Corporation, DePuy Synthes, Medtronic plc, NuVasive, Inc., Orthofix Holdings, Inc., Orthovita, Inc., Stryker Corporation, Smith & Nephew, Inc. and Wright Medical Group N.V.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Sterile Injectables buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Bone Grafts And Substitutes contains:

Analysis and forecast of Sterile Injectables market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Sterile Injectables market;

Assessment and forecast of Sterile Injectables market development;

Financial and business profiles of the leading companies in the Sterile Injectables industry.


– Up to date working Sterile Injectables data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Sterile Injectables for the period 2018 to 2026

– Planned Sterile Injectables additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Sterile Injectables projects by region, key countries, and companies

– Details of major planned Sterile Injectables projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58802

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429


CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *